Sinus Dilation Devices Market Overview
The global sinus dilation devices market size is expected to witness considerable growth in the coming years. The market is registering growth because of the surging geriatric population, technological advancements, favorable reimbursement scenario in developed nations, increasing adoption of minimally invasive surgeries, and rising prevalence of sinusitis across the world.
The different sinus dilation devices are endoscopes, balloon dilation, and stents. Among these, the balloon dilation devices category accounted for the major sinus dilation devices market in the past, which is ascribed to the rising utilization of these devices for dilating the sinus ostia via a minimally invasive surgical approach. Furthermore, these devices offer increased precision and operational flexibility, which, in turn, provides maximum access control over sinus.
Stand alone and hybrid are the two types of procedures for which sinus dilation devices are used. The standalone sinus dilation procedure category accounted for a considerable share of the sinus dilation devices market in the past. This procedure offers quick relief and reduces long last-lasting cold symptoms. The hybrid procedure category is predicted to grow at a considerable pace in the coming years because of the benefits that are associated with the sinus surgeries. The procedure combines standalone sinus dilation with functional endoscopic sinus surgery, and thus provides benefits over traditional sinus dilation procedures.
Hospitals & clinics and ambulatory surgical centers are the two major end users of sinus dilation devices. between these two, the sinus dilation devices market was dominated by the hospitals & clinics category in the past, as these facilities make extensive use of sinus dilation devices. Apart from this, the availability of innovative sinus dilation devices that provide accuracy and well-equipped hospitals in developed nations is also driving the category’s growth.
When geography is taken into consideration, North America held the largest sinus dilation devices market share in the past because of increasing incidence of chronic sinusitis and rising requirement for efficient and technologically innovative dilation procedures in the region. The Asia-Pacific region is expected to register the fastest growth in the near future due to the rising private and public healthcare expenditure and growing awareness among patients regarding minimally invasive surgeries in the region.
Sinus Dilation Devices Market Dynamics
Drivers
One of the key factors driving the sinus dilation devices market growth is the increasing adoption of different sinus dilation devices, which, in turn, is taking place due to the surging prevalence of acute and chronic sinusitis across the world. As per the American Cancer Society, cancers of the nasal cavity and paranasal sinuses are rare, but affect about 2000 people in the U.S. every year. Additionally, as per the Centers for Disease Control and Prevention, in 2017, 26.9 million people were diagnosed with sinusitis in the U.S., which constituted to about 11% of the U.S. population.
Attributed to this, the demand for technologically advanced devices is increasing rapidly in the sinus dilation devices market. The manufacturers are increasingly focusing on developing better sinusitis treatment procedures and devices. For example, the vendors have integrated camera and telescopic technologies in the existing endoscopes, which has led to the emergence of image-guided surgery. In addition to this, the manufacturers are focusing on developing methods for better drainage, which minimize side effects and reduced recovery time.
Sinus Dilation Devices Market Competitive Landscape
The major players operating in the sinus dilation devices market are introducing new and innovative products for strengthening their position in the market. For example, in December 2017, the U.S. Food and Drug Administration approved Intersect ENT Inc.’s SINUVA (mometasone furoate) sinus implant, a new approach for the treatment of recurrent nasal polyp disease in patients who have had ethmoid sinus surgery before. The device expands the sinus cavity and administers an anti-inflammatory steroid directly to the site of the polyp disease for 90 days.
Some other key players in the global sinus dilation devices market are Entellus Medical Inc., Accurate Surgical & Scientific Instruments Corporation, Medtronic plc, Sklar Surgical Instruments, SinuSys Corporation, Smith & Nephew plc, Dalent Medical, Meril Life Sciences Pvt. Ltd., and InnAccel Technologies.
